{"title":"药剂师对抗风湿药的审核。","authors":"L Takavarasha, D L Scott, T J Constable","doi":"10.1093/rheumatology/21.4.201","DOIUrl":null,"url":null,"abstract":"<p><p>The results of an audit, by a hospital pharmacist, of antirheumatic drug use at four rheumatology units are presented. Profiles can be developed for each drug which indicate their efficacy and the adverse reaction rate in clinical practice. These can be used to make rational therapeutic choices. A pharmacist can effectively collate such data to provide an unbiased information source.</p>","PeriodicalId":76486,"journal":{"name":"Rheumatology and rehabilitation","volume":"21 4","pages":"201-5"},"PeriodicalIF":0.0000,"publicationDate":"1982-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/21.4.201","citationCount":"3","resultStr":"{\"title\":\"A pharmacist's audit of antirheumatic drugs.\",\"authors\":\"L Takavarasha, D L Scott, T J Constable\",\"doi\":\"10.1093/rheumatology/21.4.201\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The results of an audit, by a hospital pharmacist, of antirheumatic drug use at four rheumatology units are presented. Profiles can be developed for each drug which indicate their efficacy and the adverse reaction rate in clinical practice. These can be used to make rational therapeutic choices. A pharmacist can effectively collate such data to provide an unbiased information source.</p>\",\"PeriodicalId\":76486,\"journal\":{\"name\":\"Rheumatology and rehabilitation\",\"volume\":\"21 4\",\"pages\":\"201-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1982-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1093/rheumatology/21.4.201\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rheumatology and rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rheumatology/21.4.201\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology and rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rheumatology/21.4.201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The results of an audit, by a hospital pharmacist, of antirheumatic drug use at four rheumatology units are presented. Profiles can be developed for each drug which indicate their efficacy and the adverse reaction rate in clinical practice. These can be used to make rational therapeutic choices. A pharmacist can effectively collate such data to provide an unbiased information source.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
